The CEO of obesity drugmaker Novo Nordisk and heads of other Danish companies met on Thursday with Denmark's Prime Minister Mette Frederiksen to discuss preparations for a ...

The 'game changing' weekly injections have helped thousands of people who need to lose weight and improve their health. But ...

Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...

Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.